Use of DDAVP as prophylaxis against postpartum hemorrhage in women with von Willebrand's disease: a case series demonstrating safety and efficacy.
Bjoring
Ana
A
Baxi
Laxmi
L
D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage*; D005260:Female; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D007231:Infant, Newborn; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy* / Q000517:prevention & control; D011256:Pregnancy Outcome; D013997:Time Factors; D016896:Treatment Outcome; D014842:von Willebrand Diseases / Q000188:drug therapy* / Q000517:prevention & control
D006490:Hemostatics; D003894:Deamino Arginine Vasopressin